Confluent Eyes Untapped $200 Mil. Neurosurgery Market For DuraSeal
This article was originally published in The Gray Sheet
Executive Summary
Confluent Surgical expects PMA approval by year-end for its DuraSeal sealant for prevention of cerebrospinal fluid (CSF) leaks in neurosurgery procedures, according to CEO Amar Sawhney